The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy

被引:3
作者
Aoyama, Toru [1 ,2 ]
Hashimoto, Itaru [1 ,2 ]
Maezawa, Yukio [1 ,2 ,3 ]
Hara, Kentaro [1 ,3 ]
Kazama, Keisuke [1 ]
Numata, Masakatsu [1 ]
Otani, Kazuki [1 ]
Sawazaki, Sho [1 ]
Cho, Haruhiko [1 ,2 ]
Morita, Junya [1 ]
Kawahara, Shinnosuke [1 ]
Tanabe, Mie [1 ]
Yukawa, Norio [1 ]
Saito, Aya [1 ]
Ogata, Takashi [2 ]
Rino, Yasushi [1 ]
Oshima, Takashi [1 ,2 ]
机构
[1] Yokohama City Univ, Dept Surg, Yokohama, Japan
[2] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Japan
[3] Komagome Hosp, Dept Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
关键词
Gastric cancer; Neutrophil; Lymphocyte; Survival; INFECTIOUS COMPLICATIONS; CHEMOTHERAPY; PROGNOSIS; RECURRENCE; SURVIVAL;
D O I
10.1007/s12029-023-00976-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim Recently, change in the neutrophil to lymphocyte ratio (cNLR) has been shown to be a promising prognostic inflammation marker in some malignancies. The aim of the present study was to evaluate the clinical impact of the cNLR in gastric cancer patients who received curative gastrectomy.Patients and Methods The present study included 450 patients who underwent curative treatment for gastric cancer between 2013 and 2017 at Kanagawa Cancer Center. The cNLR was defined as follows: cNLR = NLR at 1 month after surgery-NLR at 1 week before surgery. The prognosis and clinicopathological parameters of the increased cNLR and decreased cNLR groups were analyzed.Results The OS stratified by each clinical factor was compared using the log-rank test, and a significant difference was observed using a cutoff value of cNLR at 0.762. When comparing the patient background factors between the increased cNLR (>= 0.762) and decreased cNLR (< 0.762) groups, there were no significant differences in age, sex, T status, or N status. In the increased cNLR group, the OS rates at 3 and 5 years after surgery were 87.5% and 77.3%, respectively, while those in the decreased cNLR group were 92.8% and 87.3%, which amounted to a statistically significant difference (p = 0.041). The univariate and multivariate analyses of factors associated with OS showed that cNLR was a significant prognostic factor. When the postoperative course was compared between the two groups, the incidence rates of postoperative surgical complications and other-cause death were significantly higher in the increased cNLR group (p = 0.001 and p = 0.005, respectively).Conclusion The cNLR is one of the significant risk factors in gastric cancer patients. Our results suggested that the changes of inflammation status during perioperative periods might be a promising prognostic factor for gastrointestinal cancer patients.
引用
收藏
页码:402 / 409
页数:8
相关论文
共 20 条
[1]   Clinical Impact of Nutrition and Inflammation Assessment Tools in Gastric Cancer Treatment [J].
Aoyama, Toru ;
Hara, Kentaro ;
Kazama, Keisuke ;
Maezawa, Yukio .
ANTICANCER RESEARCH, 2022, 42 (11) :5167-5180
[2]   Clinical Influence of Anastomotic Leakage on Esophageal Cancer Survival and Recurrence [J].
Aoyama, Toru ;
Kazama, Keisuke ;
Atsumi, Yosuke ;
Tamagawa, Hiroshi ;
Tamagawa, Ayaka ;
Komori, Keisuke ;
Machida, Daisuke ;
Maezawa, Yukio ;
Kano, Kazuki ;
Hara, Kentaro ;
Murakawa, Masaaki ;
Numata, Masakatsu ;
Oshima, Takashi ;
Yukawa, Norio ;
Masuda, Munetaka ;
Rino, Yasushi .
ANTICANCER RESEARCH, 2020, 40 (01) :443-449
[3]   Adjuvant therapy for locally advanced gastric cancer [J].
Aoyama, Toru ;
Yoshikawa, Takaki .
SURGERY TODAY, 2017, 47 (11) :1295-1302
[4]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[5]   Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer [J].
Booka, Eisuke ;
Kikuchi, Hirotoshi ;
Haneda, Ryoma ;
Soneda, Wataru ;
Kawata, Sanshiro ;
Murakami, Tomohiro ;
Matsumoto, Tomohiro ;
Hiramatsu, Yoshihiro ;
Takeuchi, Hiroya .
ANTICANCER RESEARCH, 2022, 42 (06) :2977-2987
[6]   Neutrophil-to-lymphocyte ratio change predicts histological response to and oncological outcome of neoadjuvant chemotherapy for esophageal squamous cell carcinoma [J].
Hoshino, Shota ;
Takeuchi, Masashi ;
Kawakubo, Hirofumi ;
Kobayashi, Ryota ;
Matsuda, Satoru ;
Irino, Tomoyuki ;
Fukuda, Kazumasa ;
Nakamura, Rieko ;
Kitagawa, Yuko .
ESOPHAGUS, 2022, 19 (03) :426-435
[7]   Japanese classification of gastric carcinoma: 3rd English edition [J].
Sano T. ;
Kodera Y. .
GASTRIC CANCER, 2011, 14 (02) :101-112
[8]   Updated evidence on adjuvant treatments for gastric cancer [J].
Kanda, Mitsuro ;
Kodera, Yasuhiro ;
Sakamoto, Junichi .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (12) :1549-1560
[9]   The Impact of Severe Infectious Complications on Long-term Prognosis for Gastric Cancer [J].
Maezawa, Yukio ;
Aoyama, Toru ;
Ju, Mihwa ;
Komori, Keisuke ;
Kano, Kazuki ;
Sawazaki, Sho ;
Numata, Masakatsu ;
Hayashi, Tsutomu ;
Yamada, Takanobu ;
Tamagawa, Hiroshi ;
Sato, Tsutomu ;
Ogata, Takashi ;
Cho, Haruhiko ;
Oshima, Takashi ;
Yukawa, Norio ;
Yoshikawa, Takaki ;
Masuda, Munetaka ;
Rino, Yasushi .
ANTICANCER RESEARCH, 2020, 40 (07) :4067-4074
[10]   Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Colon Cancer in Elderly Patients: A Propensity Score Analysis [J].
Mazaki, Junichi ;
Katsumata, Kenji ;
Sujino, Hiroki ;
Udo, Ryutaro ;
Tago, Tomoya ;
Kasahara, Kenta ;
Kuwabara, Hiroshi ;
Enomoto, Masanobu ;
Ishizaki, Tetsuo ;
Nagakawa, Yuichi ;
Tsuchida, Akihiko .
ANTICANCER RESEARCH, 2021, 41 (09) :4471-4478